Xenon Pharmaceuticals Inc.

XENE · Healthcare

$60.00

Capitalización: 5.81B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Xenon Pharmaceuticals Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

Insider Monkey4 sept 2026, 19:06

Xenon (XENE) Heads To Europe With Data That Could Reshape Epilepsy Care

GlobeNewswire3 sept 2026, 20:01

Xenon to Present at Wells Fargo Healthcare Conference

Business Wire31 ago 2026, 14:49

BIOTECanada Announces 2026 Gold Leaf Award Winners, Recognizing Excellence Across Canada’s Biotechnology Ecosystem

GlobeNewswire28 ago 2026, 20:01

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Simply Wall St.28 ago 2026, 8:20

What Xenon Pharmaceuticals (XENE)'s New Azetukalner Phase 3 Epilepsy Data Means For Shareholders